No Data
Rallybio Initiates Phase 2 Trial Of RLYB212 To Address HPA-1a Alloimmunization And FNAIT In Pregnant Women, With Screening Underway Across European Sites For Target Enrollment Of Eight Participants
Express News | Rallybio Corp - Trial to Enroll Participants in Belgium, Netherlands, Norway, Sweden, UK
Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212
Express News | Rallybio Announces Initiation of Phase 2 Clinical Trial of Rlyb212
H.C. Wainwright Maintains Rallybio(RLYB.US) With Buy Rating, Cuts Target Price to $5
Express News | Rallybio Corporation : H.c. Wainwright Cuts Target Price to $5 From $6
No Data
No Data